TDT阴性T淋巴母细胞淋巴瘤一例及文献报道
A Case of Terminal Deoxynucleotidyl Transferase-Negative T-Lymphoblastic Lymphoma and Literature Review
DOI: 10.12677/ACM.2022.12121687, PDF,    科研立项经费支持
作者: 刘江鑫:西安医学院,陕西 西安;李文生*:陕西省人民医院病理科,陕西 西安
关键词: TDTT淋巴母细胞淋巴瘤淋巴瘤Terminal Deoxynucleotidyl Transferase T-Lymphoblast Lymphoma Lymphoma
摘要: 目的:报道一例TDT阴性T淋巴母细胞淋巴瘤。方法:采用HE染色、免疫组织化学和原位杂交EBER检测等方法回顾性分析陕西省人民医院确诊的1例TDT阴性T淋巴母细胞瘤患者,并复习相关文献。结果:患者女性,51岁,活检部位右侧胸膜,镜下粘膜内弥漫性淋巴样细胞浸润,细胞小至中等大,胞浆少,核圆形或卵圆形,核染色质细,核分裂象易见,组织挤压严重,纤维组织增生。免疫组织化学染色结果LCA,CD43,CD34,CD7阳性表达;CK,TDT,TTF-1,Syn,CgA,NSE,CD56,CD3,CD20,CD5,CD30,PAX-5、CD2,bcl-6,CD10,CD117,CD1α、ALK阴性表达;CD21未见FDC网,Ki67指数约60%。原位杂交EBER阴性。病理诊断:(胸膜)小块组织符合T淋巴母细胞淋巴瘤(TDT阴性)。结论:TDT阴性的T淋巴母细胞瘤罕见,诊断需要结合临床、形态、免疫表型等判断分析,避免误诊。
Abstract: Objective: To report a case of terminal deoxynucleotidyl transferase-negative T-lymphoblastic lymphoma. Methods: A case of terminal deoxynucleotidyl transferase-negative lymphoma diag-nosed in Shaanxi Provincial People’s Hospital was analyzed by HE staining, immunohistochemistry and EBER in situ hybridization, and reviewed related literature. Results: The female patient was 51 years old. The biopsy site is the right pleura. Under the microscope, there is diffuse lymphoid cell infiltration in the mucosa. The cells are small to medium large, the cytoplasm is few, the nucleus is round or oval, the nucleus chromatin is fine, the mitotic image is easy to see, the tissue is severely compressed, and the fibrous tissue is proliferative. Immunohistochemistry showed that these tumor cells were positive for LCA, CD43, CD34, CD7. Immunohistochemical staining negative expression includes CK, TDT, TTF-1, Syn, CgA, NSE, CD56, CD3, CD20, CD5, CD30, PAX-5, CD2, bcl-6, CD10, CD117, CD1α, ALK. CD21 showed no FDC network. Ki67 index was about 60%. EBER in situ hybridization was negative. Pathological diagnosis: (Pleural) small tissue conforms to T-lymphoblastic lymphoma (TDT negative). Conclusion: Terminal deoxynucleotidyl transferase- negative T-lymphoblastic lymphoma is rare, and the diagnosis should be combined with clinical, morphological, immunophenotypic and genetic analysis to avoid misdiagnosing as other lymphohematopoietic tumors.
文章引用:刘江鑫, 李文生. TDT阴性T淋巴母细胞淋巴瘤一例及文献报道[J]. 临床医学进展, 2022, 12(12): 11711-11719. https://doi.org/10.12677/ACM.2022.12121687

参考文献

[1] Sabattini, E., Bacci, F., Sagramoso, C., et al. (2010) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues in 2008: An Overview. Pathologica, 102, 83-87.
[2] You, M.J., Medeiros, L.J., His, E.D., et al. (2015) T-Lymphoblastic Leukemia/Lymphoma. American Journal of Clinical Pathology, 144, 411-422. [Google Scholar] [CrossRef
[3] 李智慧, 曹星玉, 吴彤. 原发耐药T淋巴母细胞淋巴瘤白血病异基因造血干细胞移植并发乳糜胸1例并文献复习[J]. 临床血液学杂志, 2013, 26(1): 23-25.
[4] 张泽秋, 刘升明. 以胸痛、晕厥为首发表现的T淋巴母细胞淋巴瘤一例[J]. 海南医学, 2017, 28(20): 3425-3426.
[5] 雷建园, 陈琳, 王原, 王萍, 李文生. TdT阴性的淋巴母细胞性白血病/淋巴瘤3例临床病理观察[J]. 诊断病理学杂志, 2020, 27(8): 556-559.
[6] 卜凡, 李毅, 王文洋, 等. T淋巴母细胞性淋巴瘤诊断学特征并文献复习[J]. 中华诊断学电子杂志, 2021, 9(4): 242-246.
[7] 郑晓丹, 谢建兰, 周小鸽. TdT阴性的T淋巴母细胞淋巴瘤1例报道[J]. 诊断病理学杂志, 2010, 17(2): 152-153.
[8] 涂频, 程静, 周晓蝶, 时姗姗, 刘标, 徐艳, 石群立. TdT阴性的T淋巴母细胞淋巴瘤1例并文献复习[J]. 临床与实验病理学杂志, 2015(4): 450-452.
[9] Hassan, M., Abdullah, H.M.A., Wahid, A. and Qamar, M.A. (2018) Terminal Deoxynucleotidyl Transferase (TdT)- Negative T-Cell Lymphoblastic Lymphoma with Loss of the T-Cell Lineage-Specific Marker CD3 at Relapse: A Rare Entity with an Aggressive Out-come. BMJ Case Reports, 2018, bcr2018224570. [Google Scholar] [CrossRef] [PubMed]
[10] Pan, X., Yu, S., Che, L., Xu, J. and Zhou, H. (2019) Terminal Deoxynucleotidyl Transferase Negative T-Cell Lymphoblastic Lymphoma from Heterotopic Warthin’s Tumor in Cervical Lymph Nodes: A Case Report and Review of Literature. International Journal of Clinical and Experimental Pathology, 12, 4167-4170.
[11] Terada, T. (2012) TDT(−), KIT(+), CD34(+), CD99(+) Precursor T Lymphoblastic Leu-kemia/Lymphoma. International Journal of Clinical and Experimental Pathology, 5, 167-170.
[12] Jaconi, M., Magni, F., Raimondo, F., et al. (2019) TdT Expression in Germ Cell Tumours: A Possible Immunohistochemical Cross-Reaction and Diagnostic Pitfall. Journal of Clinical Pathology, 72, 536-541. [Google Scholar] [CrossRef] [PubMed]
[13] You, M.J., Medeiros, L.J. and His, E.D. (2015) T-Lymphoblastic Leukemia/Lymphoma. American Journal of Clinical Pathology, 144, 411-422. [Google Scholar] [CrossRef
[14] 于兵, 杜金荣, 谢建兰, 等. T淋巴母细胞淋巴瘤/白血病的临床病理研究[J]. 中华病理学杂志, 2010, 39(7): 452-457.
[15] Cortelazzo, S., Ferreri, A., Hoelzer, D. and Ponzoni, M. (2017) Lymphoblastic Lymphoma. Critical Reviews in Oncology/Hematology, 113, 304-317. [Google Scholar] [CrossRef] [PubMed]
[16] Gao, X.Z., Wei, J.G., Li, S.L., Han, J., Wang, G.N. and Li, W.C. (2020) Mediastinal T Lymphoblastic Lymphoma/Leukemia: Clinicopathological and Prognostic Analyses of 61 Cases. Chinese Journal of Pathology, 49, 601-606.
[17] 张芬, 罗东兰, 陈玉, 武鸿美, 严金海, 骆新兰, 何娇, 罗陆桥, 刘艳辉. T细胞抗原受体(TCR)标志物βF1及TCRγ在T淋巴母细胞淋巴瘤/白血病中的表达[J]. 中华病理学杂志, 2018, 47(2): 119-122.
[18] 潘鑫艳, 冯强, 黎贵芸, 杨长绍, 杨举伦, 王丽. BIOMED-2引物系统检测T淋巴母细胞性淋巴瘤/急性淋巴细胞白血病中Ig/TCR基因重排[J]. 临床与实验病理学杂志, 2015(10): 1131-1134+1139.
[19] Yu, H., Du, Y., Xu, J. and Zhang, M. (2019) Prognostic Relevance of Genetic Variations in T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma. Translational Cancer Research, 8, 2485-2495. [Google Scholar] [CrossRef] [PubMed]
[20] Mass, J. and Alobeid, B. (2021) γδ TCR T Lymphoblastic Leukemia in a Child Presenting with Marked Hyperleukocytosis. Clinical Case Reports, 9, e04472. [Google Scholar] [CrossRef] [PubMed]